Cargando…

How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?

Objective  This study was aimed to estimate the percentage of women taking opioids post-cesarean who could be detected in a state prescription monitoring program (PMP) and characteristics of those not able to be detected. Study Design  This observational cohort study included all women with an Illin...

Descripción completa

Detalles Bibliográficos
Autores principales: Premkumar, Ashish, Speedy, Sedona E., Miller, Emily S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082207/
https://www.ncbi.nlm.nih.gov/pubmed/32206438
http://dx.doi.org/10.1055/s-0040-1708492
_version_ 1783508301857685504
author Premkumar, Ashish
Speedy, Sedona E.
Miller, Emily S.
author_facet Premkumar, Ashish
Speedy, Sedona E.
Miller, Emily S.
author_sort Premkumar, Ashish
collection PubMed
description Objective  This study was aimed to estimate the percentage of women taking opioids post-cesarean who could be detected in a state prescription monitoring program (PMP) and characteristics of those not able to be detected. Study Design  This observational cohort study included all women with an Illinois address who delivered via cesarean section and used opioids within 24 hours prior to discharge at a tertiary care hospital between August 21, 2017 and March 1, 2018. The Illinois PMP was queried for presence of an opioid prescription filled within the first 3 months postpartum. Sociodemographic and clinical factors associated with an undetectable PMP record were evaluated in bivariable and multivariable logistic regression analyses. Results  A total of 517 women underwent a cesarean delivery during the study period, of whom 344 (66.5%) met inclusion criteria. Of these women, 169 (49%) did not have a detectable PMP record of filling any outpatient postpartum prescription opioid. On bivariable and multivariable logistic regression analysis, year of delivery (2018 vs. 2017) was significantly associated with a higher incidence of detectable postpartum prescription opioid record in the PMP with increasing relative risk of detectable records in the second year of analyses ( n  = 110/244 [45%] in 2017 vs. n  = 59/100 [59%] in 2018, adjusted risk ratio [aRR] = 1.32, 95% confidence interval [CI]: 1.06–1.64, p  = 0.013). No other sociodemographic or clinical characteristics was significantly associated. Conclusion  Nearly half of women who underwent a cesarean section and who were administered opioids 24 hours prior to discharge did not have a detectable postpartum opioid prescription in the PMP. While identification of prescription filling improved with time, many of women were not detectable in the PMP system. These data call into question the accuracy of PMPs in identifying prescription opioid filling patterns in the postpartum setting.
format Online
Article
Text
id pubmed-7082207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-70822072020-03-23 How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use? Premkumar, Ashish Speedy, Sedona E. Miller, Emily S. AJP Rep Objective  This study was aimed to estimate the percentage of women taking opioids post-cesarean who could be detected in a state prescription monitoring program (PMP) and characteristics of those not able to be detected. Study Design  This observational cohort study included all women with an Illinois address who delivered via cesarean section and used opioids within 24 hours prior to discharge at a tertiary care hospital between August 21, 2017 and March 1, 2018. The Illinois PMP was queried for presence of an opioid prescription filled within the first 3 months postpartum. Sociodemographic and clinical factors associated with an undetectable PMP record were evaluated in bivariable and multivariable logistic regression analyses. Results  A total of 517 women underwent a cesarean delivery during the study period, of whom 344 (66.5%) met inclusion criteria. Of these women, 169 (49%) did not have a detectable PMP record of filling any outpatient postpartum prescription opioid. On bivariable and multivariable logistic regression analysis, year of delivery (2018 vs. 2017) was significantly associated with a higher incidence of detectable postpartum prescription opioid record in the PMP with increasing relative risk of detectable records in the second year of analyses ( n  = 110/244 [45%] in 2017 vs. n  = 59/100 [59%] in 2018, adjusted risk ratio [aRR] = 1.32, 95% confidence interval [CI]: 1.06–1.64, p  = 0.013). No other sociodemographic or clinical characteristics was significantly associated. Conclusion  Nearly half of women who underwent a cesarean section and who were administered opioids 24 hours prior to discharge did not have a detectable postpartum opioid prescription in the PMP. While identification of prescription filling improved with time, many of women were not detectable in the PMP system. These data call into question the accuracy of PMPs in identifying prescription opioid filling patterns in the postpartum setting. Thieme Medical Publishers 2020-01 2020-03-19 /pmc/articles/PMC7082207/ /pubmed/32206438 http://dx.doi.org/10.1055/s-0040-1708492 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Premkumar, Ashish
Speedy, Sedona E.
Miller, Emily S.
How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title_full How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title_fullStr How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title_full_unstemmed How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title_short How Reliable Is a Statewide Prescription Monitoring Program for Identifying Post-Cesarean Opioid Use?
title_sort how reliable is a statewide prescription monitoring program for identifying post-cesarean opioid use?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082207/
https://www.ncbi.nlm.nih.gov/pubmed/32206438
http://dx.doi.org/10.1055/s-0040-1708492
work_keys_str_mv AT premkumarashish howreliableisastatewideprescriptionmonitoringprogramforidentifyingpostcesareanopioiduse
AT speedysedonae howreliableisastatewideprescriptionmonitoringprogramforidentifyingpostcesareanopioiduse
AT milleremilys howreliableisastatewideprescriptionmonitoringprogramforidentifyingpostcesareanopioiduse